The impact of CBP expression in estrogen receptor-positive breast cancer

被引：0
|
作者：
Wafaa S. Ramadan
Iman M. Talaat
Mahmood Y. Hachim
Annette Lischka
Timo Gemoll
Raafat El-Awady
机构：
[1] University of Sharjah,Sharjah Institute for Medical Research
[2] University of Sharjah,College of Medicine
[3] University of Alexandria,Department of Pathology, Faculty of Medicine
[4] Mohammed Bin Rashid University of Medicine and Health Sciences,College of Medicine
[5] University of Lübeck and University Hospital Schleswig-Holstein,Section for Translational Surgical Oncology and Biobanking, Department of Surgery
[6] University of Sharjah,College of Pharmacy
来源：
Clinical Epigenetics | 2021年 / 13卷
关键词：
Breast cancer; CBP; GCN5; ERα; HER2; Luminal subtypes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [41] Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic
    Fu, Xiaoyong
    De Angelis, Carmine
    Schiff, Rachel
    ENDOCRINOLOGY, 2022, 163 (01)
  • [42] Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer
    Booth, Brian W.
    Inskeep, Beau D.
    Shah, Hiral
    Park, Jang Pyo
    Hay, Elizabeth J.
    Burg, Karen J. L.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [43] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [44] Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
    Ao, Ada
    Morrison, Brian J.
    Wang, Heiman
    Lopez, J. Alejandro
    Reynolds, Brent A.
    Lu, Jianrong
    PLOS ONE, 2011, 6 (04):
  • [45] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
  • [46] Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
    Ichikawa, Takahiro
    Shibata, Masahiro
    Inaishi, Takahiro
    Soeda, Ikumi
    Kanda, Mitsuro
    Hayashi, Masamichi
    Takano, Yuko
    Takeuchi, Dai
    Tsunoda, Nobuyuki
    Kodera, Yasuhiro
    Kikumori, Toyone
    CURRENT ONCOLOGY, 2021, 28 (05) : 4080 - 4092
  • [47] Factors Predicting Late Recurrence for Estrogen Receptor-Positive Breast Cancer
    Sestak, Ivana
    Dowsett, Mitch
    Zabaglo, Lila
    Lopez-Knowles, Elena
    Ferree, Sean
    Cowens, J. Wayne
    Cuzick, Jack
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (19): : 1504 - 1511
  • [48] Complete estrogen blockade in advanced postmenopausal receptor-positive breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
  • [49] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
    Yamamoto, Yutaka
    Goto-Yamaguchi, Lisa
    Takeno, Masako
    Yamamoto-Ibusuki, Mutsuko
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
  • [50] What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
    Barrios, C. H.
    Sampaio, C.
    Vinholes, J.
    Caponero, R.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1157 - 1162
12345